A clinician-focused rundown of the FDA-approved oral GLP-1 that can be taken without fasting or water restrictions.
Recap by typeshit. Full story at Medscape.
Dr Alo, a cardiologist, says he is following the cardiovascular data on these drugs closely and that it is shifting how heart disease is treated.
50:28
DOWNSIZED looks at why appetite and food noise can creep back late in the weekly cycle, and what that may say about whether a GLP-1 is still working.
Avi Roy points to trial data on drugs like Ozempic, including a 16-week study of 73 people where milkshake ratings barely changed despite reduced appetite.
Research presented at the anesthesiology meeting linked GLP-1 use with lower odds of heart attack and other heart problems. It shows an association, not proof of cause.
Jonathan and Nir Zontag compared 438,474 diabetes patients on GLP-1 drugs with a matched group. New smell and taste problems were more common but still rare, they report in JAMA.
The HSE drugs group discussed Mounjaro on Tuesday. Today only Saxenda is covered for weight loss, and Lilly has offered a significant price cut.
Loading…